Floatz logo

Tyrosinase Peptide

Intraocular Melanoma

University of Southern Californiaprotein_peptidePhase 3Dormant
BB
71/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
62/ 100
Competitive Position
89/ 100

Competitive context

64 Active assets in the Intraocular Melanoma cohort.

Asset / SponsorPhaseRating
Ifa
Craig L Slingluff, Jr
Phase 2BBB
Cyclophosphamide
Beijing Biotech
Phase 2/3BB
Sargramostim
Thomas Jefferson University
Phase 3BB
Gm-Csf
Ahmad Tarhini
Phase 2BB
Darovasertib
IDEAYA Biosciences
Phase 3BB

View all 50 →

Same molecule, other indications

Tyrosinase Peptide is also rated in:

cutaneous melanomaDormant
BBB
Indicative ·
72 / 100
View asset →
melanomaDormant
BB
Indicative ·
69 / 100
View asset →
medium/large size posterior uveal melanomaDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →